Basic Requirements for the Use of Terms for Reporting Adverse Drug Reactions (VIII): Renal and Urinary System Disorders

Authors :: M. Oster
E. Weidmann
W. Aellig
J. Venulet
M. Ten Ham
S. J. Interpharma
R. Smith-Cove
M. Leski
M. Cone
F. Spinelli
F. Rocco
B. Granbensee
J. Schou
W. Schumann
E. Baumbauer
T. Trenque
I. R. Edwards
M. M. Lumpkin
P. Krupp
W. Spiegl
J. Gallacher
G. Kreutz
G. Kremer
K. Sprenger
J. M. Weiss
Z. Bankowski
R. Bruppacher
M. Pfeiffer
K. L. Wood
J. Idanpaan-Heikkila
M. Debre
F. Sauer
Source :: Pharmacoepidemiology and Drug Safety. 6:203-211
Publication Year :: 1997
Publisher :: Wiley, 1997.

Subjects :: medicine.medical_specialty
Epidemiology
Urinary retention
business.industry
Urinary system
Urology
Glomerulonephritis
medicine.disease
RENAL VASCULITIS
Renal tubular dysfunction
medicine
Pharmacology (medical)
Drug reaction
medicine.symptom
business
Nephrotic syndrome

ISSN :: 10991557 and 10538569
Volume :: 6
Database :: OpenAIRE
Journal :: Pharmacoepidemiology and Drug Safety
Accession number :: edsair.doi...........9b432e4682fbdce8284d696ad2d8ca60
Full Text :: https://doi.org/10.1002/(sici)1099-1557(199705)6:3<203::aid-pds265>3.0.co;2-i

Full Text Access

Tools